EGFR and lung carcinoma: Many genes along the pathway, e.g., RAS and MAP 2 K1, were observed to be over-expressed in tumors in the three lung cancer data sets (Fig. 6c), confirming the downstream of tumor signals trigged by the abnormal TFAP2C-EGFR regulation.